Home
Distretto Toscano Scienze della Vita
  • Login
    • EN
    • IT
  • Industrial district
    • About us
  • REPORTS
  • NEWS
  • Home

The Cluster Network

Probiomedica

  • Medical devices/Biotech (non pharma)
  • Company information
  • Profile
  • Products/Services/Instruments
  • Additional info
Start-up: 
No
Company Size: 
Micro
Website: http://www.probiomedica.it/
 info@probiomedica.it
 
Registered office address:
Via di Santo Spirito, 14 - 50125 - Firenze-FI


Overview: 
Probiomedica, a start-up founded in 2015, combines engineering, biology, photonics and robotics and aims to develop innovative devices for applications in the service of health and the person. Probiomedica with its experts is dedicated to the study of technological innovations to be used to improve its products and create new ones. The first product of the company under development is CapsuLight, an ingestible led capsule for the treatment of infection with Helicobacter pylori. The capsule, as small as an antibiotic pill, uses simple LEDs and a normal battery, emitting light of specific wavelengths to cause the elimination of Helicobacter, without the side effects related to antibiotic-resistance. The disposable capsule is based on technologies similar to those of diagnostic endoscopic capsules, which have been commercially available for 15 years.
Sectors :
Medical devices/Biotech (non pharma)Electromedical and medical equipmentsTherapy and treatment equipment (not classified elsewhere)

Activity type: 
Design & prototyping
Research & development
Founding Year: 
2015

Products/Services

  • CapsuLight is an ingestible capsule that uses LEDs to treat Helicobacter pylori in the stomach, which can cause various diseases of the gastrointestinal system such as chronic gastritis, gastric ulcer and lymphoma. It is a small capsule the size of an antibiotic tablet, without side effects, disposable, safe as it is based on technologies available on the market for over 15 years. It acts through photochemical stimulation of the porphyryrin systems that accumulate in the bacterium, which once illuminated become cytotoxic to the bacterium itself.

Number of patents: 

2

Share Facebook Twitter Linkedin





Newsletter

Join the newsletter to keep updated about all the news, events, opportunities in life sciences


Contact Us

at Fondazione Toscana Life Sciences
Managing Body of Tuscany Life Sciences Cluster

  • Address: Via Fiorentina 1 – 53100 Siena - Italy
  • Email: info@scienzedellavita.it

Editorial board

  • Email: redazione@meetthelifesciences.it

Follow us

Privacy >

Fondazione Toscana Life Sciences - Bando Distretti Tecnologici, Azione 1.1.6 Programma regionale Fesr 2021-2027
Fondazione Toscana Life Sciences - Bando Distretti Tecnologici, Azione 1.1.6 Programma regionale Fesr 2021-2027